Serum apolipoprotein A1 and B are associated with 6-month persistent and incident diabetic macular oedema in type 2 diabetes.
Soefiandi SoedarmanMadarina JuliaTjahjono D GondhowiardjoAlberthus Donni Budi PrasetyaKing Hans KurniaMuhammad Bayu SasongkoPublished in: BMJ open ophthalmology (2023)
Individuals with diabetes with higher ApoA1 had lower risk of persistent/incident DMO and those with higher ApoB/A1 had higher risk of persistent/incident DMO at the end of 6 months. These suggest that serum ApoA1 and ApoB/A1 levels may be important risk factors for DMO and could be predictive of persistent/incident DMO despite anti-vascular endothelial growth factor treatment.